168 related articles for article (PubMed ID: 16029868)
1. The influence of methylene blue light treatment and methylene blue removal filter on fibrinogen activity states and fibrin polymerisation indices.
Depasse F; Sensebé L; Seghatchian J; Andreu G; Samama MM
Transfus Apher Sci; 2005 Aug; 33(1):63-9. PubMed ID: 16029868
[TBL] [Abstract][Full Text] [Related]
2. Photodynamic inactivation of model virus in human plasma by methylene blue and its influence on plasma proteins.
Wang D; Bu F; Xu J
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Mar; 14(1):52-5. PubMed ID: 11503026
[TBL] [Abstract][Full Text] [Related]
3. Thrombin generation capacity is impaired in methylene-blue treated plasma compared to normal levels in single-donor fresh-frozen plasma, a licensed solvent/detergent-treated plasma (Octaplas) and a development product (Uniplas).
Pock K; Heger A; Janisch S; Svae TE; Römisch J
Transfus Apher Sci; 2007 Dec; 37(3):223-31. PubMed ID: 18006380
[TBL] [Abstract][Full Text] [Related]
4. Plasma temperature during methylene blue/light treatment influences virus inactivation capacity and product quality.
Gravemann U; Handke W; Sumian C; Alvarez I; Reichenberg S; Müller TH; Seltsam A
Vox Sang; 2018 May; 113(4):368-377. PubMed ID: 29484670
[TBL] [Abstract][Full Text] [Related]
5. Storage of thawed plasma for a liquid plasma bank: impact of temperature and methylene blue pathogen inactivation.
Thiele T; Kellner S; Hron G; Wasner C; Nauck M; Zimmermann K; Wessel A; Warkentin TE; Greinacher A; Selleng K
Transfusion; 2012 Mar; 52(3):529-36. PubMed ID: 21880044
[TBL] [Abstract][Full Text] [Related]
6. Methylene blue enhances lateral association of fibrin resulting in rapid gelation and thick fiber formation.
Carr ME; Powers PL
Thromb Haemost; 1989 Apr; 61(2):230-3. PubMed ID: 2749596
[TBL] [Abstract][Full Text] [Related]
7. West Nile virus in plasma is highly sensitive to methylene blue-light treatment.
Mohr H; Knüver-Hopf J; Gravemann U; Redecker-Klein A; Müller TH
Transfusion; 2004 Jun; 44(6):886-90. PubMed ID: 15157256
[TBL] [Abstract][Full Text] [Related]
8. Changes in functional activities of plasma fibrinogen after treatment with methylene blue and red light.
Suontaka AM; Blombäck M; Chapman J
Transfusion; 2003 May; 43(5):568-75. PubMed ID: 12702176
[TBL] [Abstract][Full Text] [Related]
9. Two pathogen reduction technologies--methylene blue plus light and shortwave ultraviolet light--effectively inactivate hepatitis C virus in blood products.
Steinmann E; Gravemann U; Friesland M; Doerrbecker J; Müller TH; Pietschmann T; Seltsam A
Transfusion; 2013 May; 53(5):1010-8. PubMed ID: 22905868
[TBL] [Abstract][Full Text] [Related]
10. What's happening? The quality of methylene blue treated FFP and cryo.
Seghatchian J; Krailadsiri P
Transfus Apher Sci; 2001 Dec; 25(3):227-31. PubMed ID: 11846153
[TBL] [Abstract][Full Text] [Related]
11. Thrombin generation and clot formation in methylene blue-treated plasma and cryoprecipitate.
Cardigan R; Philpot K; Cookson P; Luddington R
Transfusion; 2009 Apr; 49(4):696-703. PubMed ID: 19170989
[TBL] [Abstract][Full Text] [Related]
12. Removal of methylene blue from plasma via an adsorbent filter.
AuBuchon JP; Pickard C; Herschel L; O'Connor JL; Lee E
Vox Sang; 1998; 74(1):1-6. PubMed ID: 9481852
[TBL] [Abstract][Full Text] [Related]
13. Cryoprecipitate prepared from plasma treated with methylene blue plus light: increasing the fibrinogen concentration.
Hornsey VS; Young DA; Docherty A; Hughes W; Prowse CV
Transfus Med; 2004 Oct; 14(5):369-74. PubMed ID: 15500456
[TBL] [Abstract][Full Text] [Related]
14. Quantitative and qualitative analysis of proteins in fresh frozen plasma obtained from whole blood donations and prepared with two photochemical treatments.
Cid J; Ramiro L; Martínez N; Palomo M; Magallon O; Claparols M; Ortiz P; Puig L; Pla RP
Transfus Apher Sci; 2008 Oct; 39(2):115-21. PubMed ID: 18710822
[TBL] [Abstract][Full Text] [Related]
15. Coagulation function in fresh-frozen plasma prepared with two photochemical treatment methods: methylene blue and amotosalen.
Osselaer JC; Debry C; Goffaux M; Pineau J; Calomme G; Dubuc E; Chatelain B; Vandendaele MC; Hsu J; Rheinschmidt M; Lin L
Transfusion; 2008 Jan; 48(1):108-17. PubMed ID: 17900283
[TBL] [Abstract][Full Text] [Related]
16. Factor VIII and fibrinogen recovery in plasma after Theraflex methylene blue-treatment: effect of plasma source and treatment time.
Rapaille A; Reichenberg S; Najdovski T; Cellier N; de Valensart N; Deneys V
Blood Transfus; 2014 Apr; 12(2):226-31. PubMed ID: 24931842
[TBL] [Abstract][Full Text] [Related]
17. Quality of methylene-blue-treated fresh-frozen plasma stored up to 27 months.
Moog R; Reichenberg S; Hoburg A; Müller N
Transfusion; 2010 Feb; 50(2):516-8. PubMed ID: 20233360
[No Abstract] [Full Text] [Related]
18. [Initial experiences with methylene blue virus inactivated fresh frozen plasma: results of a clinical and in vitro study].
Wieding JU; Neumeyer H
Infusionsther Transfusionsmed; 1992 Apr; 19(2):84-90. PubMed ID: 1623325
[TBL] [Abstract][Full Text] [Related]
19. Methylene blue-mediated photodynamic inactivation as a novel disinfectant of enterovirus 71.
Wong TW; Huang HJ; Wang YF; Lee YP; Huang CC; Yu CK
J Antimicrob Chemother; 2010 Oct; 65(10):2176-82. PubMed ID: 20719762
[TBL] [Abstract][Full Text] [Related]
20. The effect of methylene blue photoinactivation and methylene blue removal on the quality of fresh-frozen plasma.
Garwood M; Cardigan RA; Drummond O; Hornsey VS; Turner CP; Young D; Williamson LM; Prowse CV
Transfusion; 2003 Sep; 43(9):1238-47. PubMed ID: 12919426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
